From FDA clearance to the impact on benefit plan design

Authors: Dino Conti Eric McKinley

null

Telemedicine gained traction during the height of the pandemic, but it also set a precedence for the future of medicine. With the emergence of prescription digital therapeutics (PDTs), patients can use software that leverages technological advancements to address gaps in care — thus supporting safer and more clinically effective methods to prevent, manage and treat diseases across multiple therapeutic classes.

Of the 90,000 new digital health apps released in 2020, a subset of them is considered digital therapeutics. A smaller subset — ones that are prescription only — is considered prescription digital therapeutics.

Author Information

Disclaimer

Consulting and insurance brokerage services to be provided by Gallagher Benefit Services, Inc. and/or its affiliate Gallagher Benefit Services (Canada) Group Inc. Gallagher Benefit Services, Inc. is a licensed insurance agency that does business in California as "Gallagher Benefit Services of California Insurance Services" and in Massachusetts as "Gallagher Benefit Insurance Services." Neither Arthur J. Gallagher & Co., nor its affiliates provide accounting, legal or tax advice.